Active Pharmaceutical Ingredients Market Worth $353.0 Billion By 2030

The global active pharmaceutical ingredients market was valued at USD 209.7 billion and is projected to grow by USD 353 billion at a CAGR of 6% by 2030. Several driving factors for the market that contribute to its constant growth mainly include advancements in the manufacturing of active pharmaceutical ingredients, expansion of the biopharmaceutical sector, and growth in the geriatric population. 

With various advancements of biotechnological and pharmaceutical companies in therapeutic drugs, the API market is expected to witness positive global growth. The initiative to produce organ-on-a-chip models for developing predictive tissue models to test drug safety is considered a simulator for API’s market expansion. To address the medical needs, several companies are now collaborating to develop much-needed novel treatments to enhance their supply chain. 

The growing occurrence of lifestyle-based and chronic conditions like cardiovascular diseases is encouraging the API demand. Various other factors include the prevalence of chronic diseases, increased drug R&D, expansion of generics, and rising biopharmaceutical consumption. Additionally, the COVID-19 pandemic had a positive impact on the active pharmaceutical ingredients market. The key market players and several countries demanded and produced a sizeable amount of components for the treatment of COVID-19.

 To request a sample copy or view summary of this report, "please" click the link below:

 https://www.millioninsights.com/industry-reports/active-pharmaceutical-ingredients-api-market

Active Pharmaceutical Ingredients Market Report Highlights

• Due to significant market players in and around the region, North America is home to the largest API market

• India has newly gained positive attention owing to the presence of raw materials, a wide distribution network, a large workforce, and government subsidies owing to the ‘Make in India’ program

• The 2021 market was dominated by the synthetic API segment registering the highest revenue share of 72.6%

• Mar & Co., Inc., in November 2021 announced the acquisition of Acceleron Pharma which would help expand their cardiovascular portfolio and pipeline

Active Pharmaceutical Ingredients Market Report Segments

Active Pharmaceutical Ingredients Type of Synthesis Outlook (Revenue, USD Billion, 2018 - 2030)
    • Biotech
        • Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
            • Generic APIs
            • Innovative APIs
        • Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
            • Monoclonal Antibodies
            • Hormones
            • Cytokines
            • Recombinant Proteins
            • Therapeutic Enzymes
            • Vaccines
            • Blood Factors
    • Synthetic
        • Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
            • Generic APIs
            • Innovative APIs

Active Pharmaceutical Ingredients Type of Manufacturer Outlook (Revenue, USD Billion, 2018 - 2030)
    • Captive APIs
    • Merchant APIs
        • Merchant APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
            • Generic APIs
            • Innovative APIs
        • Merchant APIs Market, By Type of Synthesis (Revenue, USD Billion, 2018 - 2030)
            • Biotech
            • Synthetic

Active Pharmaceutical Ingredients Type Outlook (Revenue, USD Billion, 2018 - 2030)
    • Generic APIs
    • Innovative APIs

Active Pharmaceutical Ingredients Type of Drug (Revenue, USD Billion, 2018 - 2030)
    • Prescription Drugs
    • Over-the-counter Drugs

Active Pharmaceutical Ingredients Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Cardiovascular Diseases
    • Oncology
    • CNS and Neurology
    • Orthopedic
    • Endocrinology
    • Pulmonology
    • Gastroenterology
    • Nephrology
    • Ophthalmology
    • Others

Active Pharmaceutical Ingredients Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Hungary
    • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • Middle East & Africa
        • South Africa
        • UAE
        • Saudi Arabia
        • Egypt
        • Israel

List of Key Players in the Active Pharmaceutical Ingredients Market
    • Merck & Co., Inc.
    • AbbVie, Inc.
    • Bristol-Myers Squibb Company
    • Boehringer Ingelheim International GmbH
    • Cipla, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Albemarle Corporation
    • Viatris Inc.
    • Aurobindo Pharma
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy’s Laboratories Ltd